Summary

Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.

Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.

Some prices, such as Merck’s diabetes drugs, will be reduced.

Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.

  • @[email protected]
    link
    fedilink
    106
    edit-2
    5 months ago

    The line must go up. Doesn’t matter that homelessness increased 18% in 2024 in the US. They need that third home and a yacht.

      • @[email protected]
        link
        fedilink
        385 months ago

        Its almost like dragons and thier hoards. Just keep piling it up…

        But they’re not magestic like dragons. Still close… Lizard people? Cold blooded. Predatory. It tracks.

        • @[email protected]
          link
          fedilink
          English
          85 months ago

          Somebody did the math already; Bezos alone has more money than is depicted in Smaugs hoard in The Hobbit